Skip to main content
. 2021 Jul 26;12:688647. doi: 10.3389/fimmu.2021.688647

Figure 1.

Figure 1

Potential functions in renal ILC2. ILC2 have protective functions in kidney, but exerts positively or negatively effects in dependent on the amount of renal IL-33. Upon kidney injury and disease, IL-33 released from vascular endothelial cells and/or tubular epithelial cells leads to activate renal-resident ILC2, and secreted type2 cytokines possibly affects in following events; (A) tissue repair by inducing M2 macrophages, (B) hypertension and cardiovascular disease through renin-angiotensin system, (C) renal anemia mediated by EPO, (D) renal fibrosis via the plasticity for TGF-β producing ILCreg.